Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |